FCPM III SERVICES B.V.
Q4 2025 13F Holdings
- Locationnaarden, P7
- Num holdings
10
- Value ($000)
$762,887
- Date Filed02/17/2026
- Form type13F-HR
- CIK0002013410
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | $322.7M | 42 % | 9,198,900 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | $106.85M | 14 % | 5,462,846 | ||
ENGENE HOLDINGS INC | COM | 29286M105 | $86.98M | 11 % | 9,632,561 | ||
RAPT THERAPEUTICS INC | COM NEW | 75382E208 | $62.09M | 8 % | 1,833,333 | ||
MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | $56.67M | 7 % | 3,226,400 | ||
VOR BIOPHARMA INC | COM NEW | 929033207 | $47.31M | 6 % | 3,617,354 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | $27.3M | 4 % | 2,808,368 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | $24.56M | 3 % | 3,468,430 | ||
CRESCENT BIOPHARMA INC. | COM | G2545C104 | $19.9M | 3 % | 1,677,852 | ||
ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | $8.52M | 1 % | 2,878,148 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100